TCBIO

Texas Capital Bancshares, Inc. Depositary Shares 5.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock Series B

TCBIO
Closed
$20.64
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Texas Capital Bancshares, Inc. is a holding company, which engages in the provision of financial services and customized solutions to businesses, entrepreneurs, and individual customers. The company is headquartered in Dallas, Texas and currently employs 1,785 full-time employees. The company went IPO on 2003-08-13. The firm's business activities are conducted through its subsidiary, Texas Capital Bank. The company offers a range of products and services for its business customers, including commercial loans; real estate term and construction loans; mortgage warehouse lending and mortgage finance services; treasury management services, including online banking, foreign exchange and debit and credit card services; investment banking and advisory services, and letters of credit. The company also provides banking services for its individual customers, including personal wealth management and trust services; certificates of deposit; interest-bearing and non-interest-bearing checking accounts; traditional money market and savings accounts; loans; online and mobile banking; investment banking and advisory services, and Bask Bank.
Country

US

CEO

Mr. Robert Holmes

IPO date

2003

Employees

1,785

ISIN

US88224Q1076

Key stats

Open

$20.52

Volume

5.94K

Market cap

$4.48B

Prev. close

$20.62

Impl / hst vl

-

Open interest

$0.00

$20.52

Day’s Range

$20.70

$20.13

52W Range

$22.95

Valuation

44
Valuation score
Fairly Valued
P/E
12.45
P/S
-
NIM
0.78
ROE
9.93
Efficiency ratio
43.73
FCF growth
-34.14%
LLP / Net income
23.03%

Jun

15

Dividends

The last payment date was Jun 15, 2026

Div. per Share

$0.36

Div. Yield

1.74%

Payout Ratio

-

Div. Growth YoY

0.00%

Analysts estimates

Consensus rating
Hold

The average rating from top 8 analysts indicates that stock may significantly underperform the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$22.11
The top 16 analysts forecasts that 12-month price may increase by 7.10%, with a low of $19.40 and a high of $24.37
$19.40
Low
$22.11
Avg
$24.37
High
Current price

Earnings

Q1 ‘26 interest income
$419.09M
Q1 ‘26 net income
$69.48M
Interest income
Net income
Previous EPS
$1.56
Estimate EPS
$1.91
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply